Abstract
In PUVA (Psoralen plus UVA) chemotherapy 8-methoxypsoralen is the most widely used compound, although its efficacy is endowed with undesired side effects. In order to have an evident anti-proliferative activity with a reduced phototoxicity, many linear and angular derivatives have been synthesised. In this paper we describe a QSAR study in which, by means of the neural networks methodology, a useful model for predicting biological activity, expressed as ID50 (the UVA dose that reduces to 50% the DNA synthesis in Ehrlich cells), has been derived. A decision tree that is able to discriminate between active and inactive compounds has been built based on recursive partitioning. The study shows the key structural features responsible for the activity and could be a helpful tool in the rational design of new, less toxic, photochemotherapeuthic agents.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Parrish, J.A., Stern, R.S., Pathak, M.A., Fitzpatrick, T.B., In Regan, J.D. and Parrish, J.A. (Eds.), The Science of Photomedicine, Plenum Press: New York, NY, 1982, pp. 595–624.
Gasparro, F.P., Extracorporeal Photochemotherapy Clinical Aspects and the Molecular Basis for Efficacy, Landes Press, Georgetown, TX, 1994.
Kirkland, D.J., Creed, K.L., Mannisto, P., Mutat. Res., 116 (1983) 73.
Abel, G., Mutat. Res., 190 (1987) 63.
Stivala, L.A., Pizzala, R., Rossi, R., Melli, R., Verri, M.G., Bianchi, L., Mutat. Res., 327 (1995) 227.
Stern, R.S., Lange, R., J. Invest. Dermatol., 91 (1988) 120.
Ben-Hur, E., Song, P.S., Adv. Radiat. Biol., 11 (1984) 131.
Bordin, F., Carlassare, F., Busulini, L., Baccichetti, F., Photochem. Photobiol., 58 (1993) 133.
Guiotto, A., Rodighiero, P., Manzini, P., Pastorini, G., Bordin, F., Baccichetti, F., Carlassare, F., Vedaldi, D., Dall'Acqua, F., Tamaro, M., Recchia, G., Cristofolini, M., J. Med. Chem., 27 (1984) 959.
Bordin, F., Dall'Acqua, F., Guiotto, A., Pharmac. Ther., 52 (1991) 331.
Mosti L., Schenone, P., Menozzi G., Romussi, G., Baccichetti, F., Carlassare F., Vedaldi D., Bordin, F., Eur. J.Med. Chem., 18 (1983) 113.
Mosti L., Schenone, P., Menozzi G., Romussi, G., Baccichetti, F., Carlassare F., Bordin, F., Farmaco, 39 (1984) 81.
Iester, M., Fossa, P., Menozzi, G., Mosti, L., Baccichetti F., Marzano, C., Simonato, M., Farmaco, 50 (1995) 669.
Mosti, L., Lo Presti, E., Menozzi, G., Marzano, C., Baccichetti, F., Falcone, G., Filippelli, W. and Piucci, B., Farmaco, 53 (1998) 602.
Fossa, P., Mosti, L., Menozzi, G., Marzano, C., Baccichetti, F., Bordin, F., Bioorg. Med. Chem. Lett., 10 (2002) 743.
Dall'Acqua, F., Vedaldi, D., Caffieri, S., Guiotto, A., Rodighiero, P., Baccichetti, F., Carlassare, F., Bordin, F., J. Med. Chem., 24 (1981) 178.
Dall'Acqua, F., Vedaldi, D., Guiotto, A., Rodighiero, P., Carlassare, F., Baccichetti, F., Bordin, F., J. Med. Chem., 24 (1981) 806.
Guiotto, A., Rodighiero, P., Pastorini, G., Bordin, F., Baccichetti, F., Carlassare, F., Vedaldi, D., Dall'Acqua, F., Farmaco, 36 (1981) 537.
Kolomogorov, A.N., Doklady Akademiia Nauk SSSR, 114 (1957) 953.
Duprat, A.F., Huynh, T., Dreyfus, G., J. Chem. Inf. Comput. Sci., 38 (1998) 586.
Cerius2TM http://www.accelrys.com
MATLABTM http://www.mathworks.com
Hagan, M.T., Menhaj, M., IEEE Transactions on Neural Networks, 5 (1994) 989.
Tetko, I.V., Livingstone, D.J., Luik, A.I., J. Chem. Inf. Comput. Sci., 35 (1995) 826.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Giordanetto, F., Fossa, P., Menozzi, G. et al. In silico rationalization of the structural and physicochemical requirements for photobiological activity in angelicine derivatives and their heteroanalogues. J Comput Aided Mol Des 17, 53–64 (2003). https://doi.org/10.1023/A:1024557113083
Issue Date:
DOI: https://doi.org/10.1023/A:1024557113083